Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Periodicals
EU seeks easier access to generic medicines, Reuters says » 14:48
11/23/20
11/23
14:48
11/23/20
14:48
JNJ

Johnson & Johnson

$143.20 /

-1.13 (-0.78%)

, LLY

Eli Lilly

$142.01 /

-3.63 (-2.49%)

, MRK

Merck

$79.63 /

-0.81 (-1.01%)

, PFE

Pfizer

$36.32 /

-0.38 (-1.04%)

, SNY

Sanofi

$49.53 /

-0.93 (-1.84%)

, AZN

AstraZeneca

$54.26 /

-1.03 (-1.86%)

, GSK

GlaxoSmithKline

$36.54 /

-0.49 (-1.32%)

, NVS

Novartis

$87.00 /

-0.505 (-0.58%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

, BMY

Bristol-Myers

$61.26 /

-0.365 (-0.59%)

The European Commission…

The European Commission is seeking to make it easier for patients to gain access to cheaper, generic medicines, in a move that could affect the revenues of large pharmaceutical companies, Reuters' Francesco Guarascio reports, citing a draft EU document. The document explains the EU executive's strategy for the sector in a document due to be published later this week, with the goal of making drugs more affordable and preventing the serious shortages seen in the first phase of the coronavirus crisis earlier this year, the author says. "The Commission will consider targeted policies that support greater generic and biosimilar competition," the document says. Publicly traded companies in the space include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY). Reference Link

ShowHide Related Items >><<
SNY Sanofi
$49.53 /

-0.93 (-1.84%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PFE Pfizer
$36.32 /

-0.38 (-1.04%)

NVS Novartis
$87.00 /

-0.505 (-0.58%)

MRK Merck
$79.63 /

-0.81 (-1.01%)

LLY Eli Lilly
$142.01 /

-3.63 (-2.49%)

JNJ Johnson & Johnson
$143.20 /

-1.13 (-0.78%)

GSK GlaxoSmithKline
$36.54 /

-0.49 (-1.32%)

BMY Bristol-Myers
$61.26 /

-0.365 (-0.59%)

AZN AstraZeneca
$54.26 /

-1.03 (-1.86%)

JNJ Johnson & Johnson
$143.20 /

-1.13 (-0.78%)

08:46 Today SVB Leerink
AstraZeneca vaccine 'will never be licensed in the U.S.,' says SVB Leerink
11/12/20 Chardan
Immunovant price target raised to $60 from $45 at Chardan
11/10/20 Piper Sandler
Aligos Therapeutics initiated with an Overweight at Piper Sandler
10/26/20 RBC Capital
Morphic Holding initiated with an Outperform at RBC Capital
LLY Eli Lilly
$142.01 /

-3.63 (-2.49%)

11/20/20 Stifel
Precision BioSciences price target raised to $22 from $21 at Stifel
11/17/20 Mizuho
Eli Lilly price target lowered to $156 from $164 at Mizuho
11/10/20 Bernstein
Eli Lilly initiated with a Market Perform, $150 price target at Bernstein
11/10/20 Bernstein
Eli Lilly initiated with a Market Perform at Bernstein
MRK Merck
$79.63 /

-0.81 (-1.01%)

11/10/20 Bernstein
Bernstein bullish on Merck, initiates with an Outperform
11/10/20 Bernstein
Merck initiated with an Outperform at Bernstein
11/02/20 Raymond James
Jounce Therapeutics downgraded to Market Perform at Raymond James
10/23/20
Fly Intel: Pre-market Movers
PFE Pfizer
$36.32 /

-0.38 (-1.04%)

11/19/20
Fly Intel: Top five analyst initiations
11/19/20 Goldman Sachs
Pfizer reinstated with a Neutral at Goldman Sachs
11/17/20 Benchmark
Inovio on 'top-10 vaccine contenders list,' says Benchmark
11/17/20 Maxim
Co-Diagnostics price target lowered to $20 from $30 at Maxim
SNY Sanofi
$49.53 /

-0.93 (-1.84%)

11/03/20 Morgan Stanley
Sanofi price target lowered to EUR 105 from EUR 107 at Morgan Stanley
10/30/20 JPMorgan
Sanofi price target lowered to EUR 100 from EUR 106 at JPMorgan
10/06/20 Raymond James
Raymond James says FDA guidance 'likely assures' no vaccine EUA before late Nov.
10/04/20 Goldman Sachs
Translate Bio initiated with a Buy at Goldman Sachs
AZN AstraZeneca
$54.26 /

-1.03 (-1.86%)

11:53 Today Morgan Stanley
AstraZeneca price target raised to 9,400 GBp from 9,000 GBp at Morgan Stanley
11/11/20 Oppenheimer
Amgen price target raised to $280 from $275 at Oppenheimer
11/11/20 HSBC
AstraZeneca upgraded to Hold from Reduce at HSBC
GSK GlaxoSmithKline
$36.54 /

-0.49 (-1.32%)

11/13/20 Morgan Stanley
GlaxoSmithKline upgraded to Equal Weight from Underweight at Morgan Stanley
11/02/20 Liberum
GlaxoSmithKline upgraded to Buy from Hold at Liberum
10/30/20 Barclays
GlaxoSmithKline price target lowered to 1,300 GBp from 1,550 GBp at Barclays
10/27/20 Truist
AnaptysBio price target raised to $27 from $20 at Truist
NVS Novartis
$87.00 /

-0.505 (-0.58%)

11/10/20 JPMorgan
Novartis price target raised to CHF 85 from CHF 82 at JPMorgan
10/26/20 JMP Securities
Kura Oncology price target raised to $33 from $22 at JMP Securities
09/29/20 Berenberg
Novartis initiated with a Buy at Berenberg
09/24/20 Barclays
Regenxbio price target lowered to $79 from $88 at Barclays
RHHBY Roche
$0.00 /

+ (+0.00%)

11/11/20 Truist
Opthea initiated with a Buy at Truist
10/16/20 UBS
Roche price target lowered to CHF 370 from CHF 390 at UBS
10/06/20 Goldman Sachs
Goldman reiterates $34 target on Kiniksa after 'impressive' data
09/29/20 Berenberg
Roche initiated with a Hold at Berenberg
BMY Bristol-Myers
$61.26 /

-0.365 (-0.59%)

09:48 Today BofA
BofA upgrades Schrodinger to Buy after 'major' collaboration announcement
11/17/20 Mizuho
Bristol-Myers Squibb CVR price target lowered to $3.34 from $6.17 at Mizuho
11/16/20 Societe Generale
Bristol-Myers upgraded to Buy from Hold at Societe Generale
11/10/20 Bernstein
Bristol-Myers initiated with a Market Perform, $72 price target at Bernstein
SNY Sanofi
$49.53 /

-0.93 (-1.84%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PFE Pfizer
$36.32 /

-0.38 (-1.04%)

NVS Novartis
$87.00 /

-0.505 (-0.58%)

MRK Merck
$79.63 /

-0.81 (-1.01%)

LLY Eli Lilly
$142.01 /

-3.63 (-2.49%)

JNJ Johnson & Johnson
$143.20 /

-1.13 (-0.78%)

GSK GlaxoSmithKline
$36.54 /

-0.49 (-1.32%)

BMY Bristol-Myers
$61.26 /

-0.365 (-0.59%)

AZN AstraZeneca
$54.26 /

-1.03 (-1.86%)

SNY Sanofi
$49.53 /

-0.93 (-1.84%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PFE Pfizer
$36.32 /

-0.38 (-1.04%)

NVS Novartis
$87.00 /

-0.505 (-0.58%)

MRK Merck
$79.63 /

-0.81 (-1.01%)

LLY Eli Lilly
$142.01 /

-3.63 (-2.49%)

JNJ Johnson & Johnson
$143.20 /

-1.13 (-0.78%)

GSK GlaxoSmithKline
$36.54 /

-0.49 (-1.32%)

BMY Bristol-Myers
$61.26 /

-0.365 (-0.59%)

AZN AstraZeneca
$54.26 /

-1.03 (-1.86%)

SNY Sanofi
$49.53 /

-0.93 (-1.84%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PFE Pfizer
$36.32 /

-0.38 (-1.04%)

NVS Novartis
$87.00 /

-0.505 (-0.58%)

MRK Merck
$79.63 /

-0.81 (-1.01%)

LLY Eli Lilly
$142.01 /

-3.63 (-2.49%)

JNJ Johnson & Johnson
$143.20 /

-1.13 (-0.78%)

GSK GlaxoSmithKline
$36.54 /

-0.49 (-1.32%)

BMY Bristol-Myers
$61.26 /

-0.365 (-0.59%)

AZN AstraZeneca
$54.26 /

-1.03 (-1.86%)

PFE Pfizer
$36.32 /

-0.38 (-1.04%)

MRK Merck
$79.63 /

-0.81 (-1.01%)

LLY Eli Lilly
$142.01 /

-3.63 (-2.49%)

JNJ Johnson & Johnson
$143.20 /

-1.13 (-0.78%)

GSK GlaxoSmithKline
$36.54 /

-0.49 (-1.32%)

BMY Bristol-Myers
$61.26 /

-0.365 (-0.59%)

AZN AstraZeneca
$54.26 /

-1.03 (-1.86%)

Yesterday
On The Fly
Opening Day: Yatsen soars in debut, raises $617M in U.S. IPO » 08:31
11/22/20
11/22
08:31
11/22/20
08:31
NGMS

Neogames

$20.75 /

-0.99 (-4.55%)

, TLS

Telos

$19.25 /

-0.8 (-3.99%)

, MRVI

Maravai Lifesciences

$29.75 /

-1.935 (-6.11%)

, SHC

Sotera Health

$25.03 /

-1.87 (-6.95%)

, YSG

Yatsen

$20.54 /

+2.025 (+10.94%)

, OLMA

Olema Pharmaceuticals

$48.76 /

+0.2 (+0.41%)

, LSAQ

LifeSci Acquisition II

$10.05 /

+0.02 (+0.20%)

, CHFW

Consonance-HFW Acquisition

$0.00 /

+ (+0.00%)

, RTPZ

Reinvent Technology Partners Z

$0.00 /

+ (+0.00%)

, JYAC

Jiya Acquisition

$9.97 /

-0.01 (-0.10%)

, OTRA

OTR Acquisition

$0.00 /

+ (+0.00%)

, ZNTE

Zanite Acquisition

$0.00 /

+ (+0.00%)

, PIPP

Pine Island Acquisition

$0.00 /

+ (+0.00%)

, AIRB

Airbnb

$0.00 /

+ (+0.00%)

, DASH

DoorDash

$0.00 /

+ (+0.00%)

, AFRM

Affirm

$0.00 /

+ (+0.00%)

, RBLX

Roblox

$0.00 /

+ (+0.00%)

, HOMS

Caliber Home Loans

$0.00 /

+ (+0.00%)

, SGTX

Sigilon Therapeutics

$0.00 /

+ (+0.00%)

, NVS

Novartis

$87.51 /

+0.285 (+0.33%)

, PYPL

PayPal

$192.65 /

+1.54 (+0.81%)

Yatsen, a Chinese…

ShowHide Related Items >><<
PYPL PayPal
$192.65 /

+1.54 (+0.81%)

NVS Novartis
$87.51 /

+0.285 (+0.33%)

AIRB Airbnb
$0.00 /

+ (+0.00%)

NGMS Neogames
$20.75 /

-0.99 (-4.55%)

TLS Telos
$19.25 /

-0.8 (-3.99%)

MRVI Maravai Lifesciences
$29.75 /

-1.935 (-6.11%)

SHC Sotera Health
$25.03 /

-1.87 (-6.95%)

YSG Yatsen
$20.54 /

+2.025 (+10.94%)

OLMA Olema Pharmaceuticals
$48.76 /

+0.2 (+0.41%)

LSAQ LifeSci Acquisition II
$10.05 /

+0.02 (+0.20%)

CHFW Consonance-HFW Acquisition
$0.00 /

+ (+0.00%)

RTPZ Reinvent Technology Partners Z
$0.00 /

+ (+0.00%)

JYAC Jiya Acquisition
$9.97 /

-0.01 (-0.10%)

OTRA OTR Acquisition
$0.00 /

+ (+0.00%)

ZNTE Zanite Acquisition
$0.00 /

+ (+0.00%)

PIPP Pine Island Acquisition
$0.00 /

+ (+0.00%)

AIRB Airbnb
$0.00 /

+ (+0.00%)

DASH DoorDash
$0.00 /

+ (+0.00%)

07/08/20 Wedbush
Postmates stronger fit for Uber, less market share than GrubHub, says Wedbush
07/06/20 Wedbush
Uber's acquisition of Postmates 'a smart strategic move,' says Wedbush
AFRM Affirm
$0.00 /

+ (+0.00%)

RBLX Roblox
$0.00 /

+ (+0.00%)

HOMS Caliber Home Loans
$0.00 /

+ (+0.00%)

SGTX Sigilon Therapeutics
$0.00 /

+ (+0.00%)

NVS Novartis
$87.51 /

+0.285 (+0.33%)

11/10/20 JPMorgan
Novartis price target raised to CHF 85 from CHF 82 at JPMorgan
10/26/20 JMP Securities
Kura Oncology price target raised to $33 from $22 at JMP Securities
09/29/20 Berenberg
Novartis initiated with a Buy at Berenberg
09/24/20 Barclays
Regenxbio price target lowered to $79 from $88 at Barclays
PYPL PayPal
$192.65 /

+1.54 (+0.81%)

11/19/20 Morgan Stanley
Growth of Square's Cash App may be impacted by needed fixes, says Morgan Stanley
11/19/20 Keefe Bruyette
Too early to know if new Google Pay is PayPal, Square threat, says KBW
11/10/20 Mizuho
PayPal price target lowered to $270 from $290 at Mizuho
11/05/20 DZ Bank
PayPal upgraded to Buy from Hold at DZ Bank
PYPL PayPal
$192.65 /

+1.54 (+0.81%)

NVS Novartis
$87.51 /

+0.285 (+0.33%)

  • 20
    Nov
  • 20
    Nov
  • 19
    Nov
  • 19
    Nov
  • 20
    Nov
  • 19
    Nov
  • 19
    Nov
  • 29
    Oct
PYPL PayPal
$192.65 /

+1.54 (+0.81%)

NVS Novartis
$87.51 /

+0.285 (+0.33%)

DASH DoorDash
$0.00 /

+ (+0.00%)

AIRB Airbnb
$0.00 /

+ (+0.00%)

PYPL PayPal
$192.65 /

+1.54 (+0.81%)

NVS Novartis
$87.51 /

+0.285 (+0.33%)

NGMS Neogames
$20.75 /

-0.99 (-4.55%)

HOMS Caliber Home Loans
$0.00 /

+ (+0.00%)

DASH DoorDash
$0.00 /

+ (+0.00%)

AIRB Airbnb
$0.00 /

+ (+0.00%)

PYPL PayPal
$192.65 /

+1.54 (+0.81%)

Saturday
On The Fly
Week in review: How Trump's policies moved stocks » 09:03
11/21/20
11/21
09:03
11/21/20
09:03
REGN

Regeneron

$519.36 /

+4.81 (+0.93%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

, IFNNY

Infineon

$0.00 /

+ (+0.00%)

, AZN

AstraZeneca

$55.29 /

+1.27 (+2.35%)

, BMY

Bristol-Myers

$61.62 /

-0.47 (-0.76%)

, LLY

Eli Lilly

$145.62 /

+2.16 (+1.51%)

, GSK

GlaxoSmithKline

$37.03 /

-0.11 (-0.30%)

, JNJ

Johnson & Johnson

$146.33 /

-0.76 (-0.52%)

, MRK

Merck

$80.46 /

+0.04 (+0.05%)

, NVS

Novartis

$87.51 /

+0.285 (+0.33%)

, PFE

Pfizer

$36.70 /

+0.51 (+1.41%)

, SNY

Sanofi

$50.47 /

-0.34 (-0.67%)

Catch up on the top…

ShowHide Related Items >><<
SNY Sanofi
$50.47 /

-0.34 (-0.67%)

RHHBY Roche
$0.00 /

+ (+0.00%)

REGN Regeneron
$519.36 /

+4.81 (+0.93%)

PFE Pfizer
$36.70 /

+0.51 (+1.41%)

NVS Novartis
$87.51 /

+0.285 (+0.33%)

MRK Merck
$80.46 /

+0.04 (+0.05%)

LLY Eli Lilly
$145.62 /

+2.16 (+1.51%)

JNJ Johnson & Johnson
$146.33 /

-0.76 (-0.52%)

IFNNY Infineon
$0.00 /

+ (+0.00%)

GSK GlaxoSmithKline
$37.03 /

-0.11 (-0.30%)

BMY Bristol-Myers
$61.62 /

-0.47 (-0.76%)

AZN AstraZeneca
$55.29 /

+1.27 (+2.35%)

REGN Regeneron
$519.36 /

+4.81 (+0.93%)

11/11/20 Truist
Opthea initiated with a Buy at Truist
11/10/20 SVB Leerink
Regeneron price target lowered to $643 from $653 at SVB Leerink
11/06/20 Truist
Regeneron price target raised to $770 from $750 at Truist
11/05/20 Piper Sandler
Regeneron shares will continue moving higher, says Piper Sandler
RHHBY Roche
$0.00 /

+ (+0.00%)

10/16/20 UBS
Roche price target lowered to CHF 370 from CHF 390 at UBS
10/06/20 Goldman Sachs
Goldman reiterates $34 target on Kiniksa after 'impressive' data
09/29/20 Berenberg
Roche initiated with a Hold at Berenberg
IFNNY Infineon
$0.00 /

+ (+0.00%)

11/10/20 Morgan Stanley
Infineon price target raised to EUR 30.50 from EUR 30 at Morgan Stanley
11/10/20 Deutsche Bank
Infineon price target raised to EUR 33 from EUR 27 at Deutsche Bank
11/05/20 Credit Suisse
Infineon price target raised to EUR 22.50 from EUR 19.20 at Credit Suisse
10/26/20 Morgan Stanley
Infineon price target raised to EUR 30 from EUR 25 at Morgan Stanley
AZN AstraZeneca
$55.29 /

+1.27 (+2.35%)

11/11/20 Oppenheimer
Amgen price target raised to $280 from $275 at Oppenheimer
11/11/20 HSBC
AstraZeneca upgraded to Hold from Reduce at HSBC
11/11/20 HSBC
AstraZeneca upgraded to Hold from Reduce at HSBC
10/23/20 Stifel
FibroGen safety data mitigates concerns of roxadustat black box, says Stifel
BMY Bristol-Myers
$61.62 /

-0.47 (-0.76%)

11/17/20 Mizuho
Bristol-Myers Squibb CVR price target lowered to $3.34 from $6.17 at Mizuho
11/16/20 Societe Generale
Bristol-Myers upgraded to Buy from Hold at Societe Generale
11/10/20 Bernstein
Bristol-Myers initiated with a Market Perform, $72 price target at Bernstein
11/10/20 Bernstein
Bristol-Myers initiated with a Market Perform at Bernstein
LLY Eli Lilly
$145.62 /

+2.16 (+1.51%)

11/20/20 Stifel
Precision BioSciences price target raised to $22 from $21 at Stifel
11/17/20 Mizuho
Eli Lilly price target lowered to $156 from $164 at Mizuho
11/10/20 Bernstein
Eli Lilly initiated with a Market Perform, $150 price target at Bernstein
11/10/20 Bernstein
Eli Lilly initiated with a Market Perform at Bernstein
GSK GlaxoSmithKline
$37.03 /

-0.11 (-0.30%)

11/13/20 Morgan Stanley
GlaxoSmithKline upgraded to Equal Weight from Underweight at Morgan Stanley
11/02/20 Liberum
GlaxoSmithKline upgraded to Buy from Hold at Liberum
10/30/20 Barclays
GlaxoSmithKline price target lowered to 1,300 GBp from 1,550 GBp at Barclays
10/27/20 Truist
AnaptysBio price target raised to $27 from $20 at Truist
JNJ Johnson & Johnson
$146.33 /

-0.76 (-0.52%)

11/12/20 Chardan
Immunovant price target raised to $60 from $45 at Chardan
11/10/20 Piper Sandler
Aligos Therapeutics initiated with an Overweight at Piper Sandler
10/26/20 RBC Capital
Morphic Holding initiated with an Outperform at RBC Capital
10/14/20 Credit Suisse
Johnson & Johnson price target raised to $168 from $163 at Credit Suisse
MRK Merck
$80.46 /

+0.04 (+0.05%)

11/10/20 Bernstein
Bernstein bullish on Merck, initiates with an Outperform
11/10/20 Bernstein
Merck initiated with an Outperform at Bernstein
11/02/20 Raymond James
Jounce Therapeutics downgraded to Market Perform at Raymond James
10/23/20
Fly Intel: Pre-market Movers
NVS Novartis
$87.51 /

+0.285 (+0.33%)

11/10/20 JPMorgan
Novartis price target raised to CHF 85 from CHF 82 at JPMorgan
10/26/20 JMP Securities
Kura Oncology price target raised to $33 from $22 at JMP Securities
09/29/20 Berenberg
Novartis initiated with a Buy at Berenberg
09/24/20 Barclays
Regenxbio price target lowered to $79 from $88 at Barclays
PFE Pfizer
$36.70 /

+0.51 (+1.41%)

11/19/20
Fly Intel: Top five analyst initiations
11/19/20 Goldman Sachs
Pfizer reinstated with a Neutral at Goldman Sachs
11/17/20 Benchmark
Inovio on 'top-10 vaccine contenders list,' says Benchmark
11/17/20 Maxim
Co-Diagnostics price target lowered to $20 from $30 at Maxim
SNY Sanofi
$50.47 /

-0.34 (-0.67%)

11/03/20 Morgan Stanley
Sanofi price target lowered to EUR 105 from EUR 107 at Morgan Stanley
10/30/20 JPMorgan
Sanofi price target lowered to EUR 100 from EUR 106 at JPMorgan
10/06/20 Raymond James
Raymond James says FDA guidance 'likely assures' no vaccine EUA before late Nov.
10/04/20 Goldman Sachs
Translate Bio initiated with a Buy at Goldman Sachs
SNY Sanofi
$50.47 /

-0.34 (-0.67%)

RHHBY Roche
$0.00 /

+ (+0.00%)

REGN Regeneron
$519.36 /

+4.81 (+0.93%)

PFE Pfizer
$36.70 /

+0.51 (+1.41%)

NVS Novartis
$87.51 /

+0.285 (+0.33%)

MRK Merck
$80.46 /

+0.04 (+0.05%)

LLY Eli Lilly
$145.62 /

+2.16 (+1.51%)

JNJ Johnson & Johnson
$146.33 /

-0.76 (-0.52%)

GSK GlaxoSmithKline
$37.03 /

-0.11 (-0.30%)

BMY Bristol-Myers
$61.62 /

-0.47 (-0.76%)

AZN AstraZeneca
$55.29 /

+1.27 (+2.35%)

  • 27
    May
SNY Sanofi
$50.47 /

-0.34 (-0.67%)

RHHBY Roche
$0.00 /

+ (+0.00%)

REGN Regeneron
$519.36 /

+4.81 (+0.93%)

PFE Pfizer
$36.70 /

+0.51 (+1.41%)

NVS Novartis
$87.51 /

+0.285 (+0.33%)

MRK Merck
$80.46 /

+0.04 (+0.05%)

LLY Eli Lilly
$145.62 /

+2.16 (+1.51%)

JNJ Johnson & Johnson
$146.33 /

-0.76 (-0.52%)

IFNNY Infineon
$0.00 /

+ (+0.00%)

GSK GlaxoSmithKline
$37.03 /

-0.11 (-0.30%)

BMY Bristol-Myers
$61.62 /

-0.47 (-0.76%)

AZN AstraZeneca
$55.29 /

+1.27 (+2.35%)

SNY Sanofi
$50.47 /

-0.34 (-0.67%)

RHHBY Roche
$0.00 /

+ (+0.00%)

REGN Regeneron
$519.36 /

+4.81 (+0.93%)

PFE Pfizer
$36.70 /

+0.51 (+1.41%)

NVS Novartis
$87.51 /

+0.285 (+0.33%)

MRK Merck
$80.46 /

+0.04 (+0.05%)

LLY Eli Lilly
$145.62 /

+2.16 (+1.51%)

JNJ Johnson & Johnson
$146.33 /

-0.76 (-0.52%)

GSK GlaxoSmithKline
$37.03 /

-0.11 (-0.30%)

BMY Bristol-Myers
$61.62 /

-0.47 (-0.76%)

AZN AstraZeneca
$55.29 /

+1.27 (+2.35%)

REGN Regeneron
$519.36 /

+4.81 (+0.93%)

PFE Pfizer
$36.70 /

+0.51 (+1.41%)

MRK Merck
$80.46 /

+0.04 (+0.05%)

LLY Eli Lilly
$145.62 /

+2.16 (+1.51%)

JNJ Johnson & Johnson
$146.33 /

-0.76 (-0.52%)

GSK GlaxoSmithKline
$37.03 /

-0.11 (-0.30%)

BMY Bristol-Myers
$61.62 /

-0.47 (-0.76%)

AZN AstraZeneca
$55.29 /

+1.27 (+2.35%)

Friday
Hot Stocks
Trump to sign orders in effort to cut prescription drug prices » 16:52
11/20/20
11/20
16:52
11/20/20
16:52
JNJ

Johnson & Johnson

$146.33 /

-0.76 (-0.52%)

, LLY

Eli Lilly

$145.62 /

+2.16 (+1.51%)

, MRK

Merck

$80.46 /

+0.04 (+0.05%)

, PFE

Pfizer

$36.70 /

+0.51 (+1.41%)

, SNY

Sanofi

$50.47 /

-0.34 (-0.67%)

, AZN

AstraZeneca

$55.29 /

+1.27 (+2.35%)

, GSK

GlaxoSmithKline

$37.03 /

-0.11 (-0.30%)

, NVS

Novartis

$87.51 /

+0.285 (+0.33%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

, BMY

Bristol-Myers

$61.62 /

-0.47 (-0.76%)

U.S. President Donald…

U.S. President Donald Trump announced that his administration is issuing two rules to "very dramatically" lower the price of prescription drugs for the American people, especially for seniors. The first action will be to prevent middlemen from "ripping off" Medicare patients with high prescription prices. The second action the administration is finalizing will " transform the way the U.S. government pays for drugs to end global freeloading on the backs of American citizens and American patients," the president said. "Medicare will now look at the price that other developed nations pay for their drugs," Trump added. "And instead of paying the highest price on that list - and we are substantially higher than any other country in the world - we will pay the lowest price. In other words, we take the lowest price, and we match whatever the lowest price is, leading to colossal savings for all Americans. And we're talking about savings of 50, 60, 70 percent, 80 percent - different drugs, different prices." Trump also announced that the White House is ending the Unapproved Drugs Initiative program to put a stop to the "unfair" practice of allowing drug companies to identify certain older generic drugs that have been widely available for decades and exploit a misguided program called "Unapproved Drugs Initiative" to obtain market exclusivity on these medicines. Publicly traded companies in the space include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY). Reference Link

ShowHide Related Items >><<
SNY Sanofi
$50.47 /

-0.34 (-0.67%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PFE Pfizer
$36.70 /

+0.51 (+1.41%)

NVS Novartis
$87.51 /

+0.285 (+0.33%)

MRK Merck
$80.46 /

+0.04 (+0.05%)

LLY Eli Lilly
$145.62 /

+2.16 (+1.51%)

JNJ Johnson & Johnson
$146.33 /

-0.76 (-0.52%)

GSK GlaxoSmithKline
$37.03 /

-0.11 (-0.30%)

BMY Bristol-Myers
$61.62 /

-0.47 (-0.76%)

AZN AstraZeneca
$55.29 /

+1.27 (+2.35%)

JNJ Johnson & Johnson
$146.33 /

-0.76 (-0.52%)

11/12/20 Chardan
Immunovant price target raised to $60 from $45 at Chardan
11/10/20 Piper Sandler
Aligos Therapeutics initiated with an Overweight at Piper Sandler
10/26/20 RBC Capital
Morphic Holding initiated with an Outperform at RBC Capital
10/14/20 Credit Suisse
Johnson & Johnson price target raised to $168 from $163 at Credit Suisse
LLY Eli Lilly
$145.62 /

+2.16 (+1.51%)

11/20/20 Stifel
Precision BioSciences price target raised to $22 from $21 at Stifel
11/17/20 Mizuho
Eli Lilly price target lowered to $156 from $164 at Mizuho
11/10/20 Bernstein
Eli Lilly initiated with a Market Perform, $150 price target at Bernstein
11/10/20 Bernstein
Eli Lilly initiated with a Market Perform at Bernstein
MRK Merck
$80.46 /

+0.04 (+0.05%)

11/10/20 Bernstein
Bernstein bullish on Merck, initiates with an Outperform
11/10/20 Bernstein
Merck initiated with an Outperform at Bernstein
11/02/20 Raymond James
Jounce Therapeutics downgraded to Market Perform at Raymond James
10/23/20
Fly Intel: Pre-market Movers
PFE Pfizer
$36.70 /

+0.51 (+1.41%)

11/19/20
Fly Intel: Top five analyst initiations
11/19/20 Goldman Sachs
Pfizer reinstated with a Neutral at Goldman Sachs
11/17/20 Benchmark
Inovio on 'top-10 vaccine contenders list,' says Benchmark
11/17/20 Maxim
Co-Diagnostics price target lowered to $20 from $30 at Maxim
SNY Sanofi
$50.47 /

-0.34 (-0.67%)

11/03/20 Morgan Stanley
Sanofi price target lowered to EUR 105 from EUR 107 at Morgan Stanley
10/30/20 JPMorgan
Sanofi price target lowered to EUR 100 from EUR 106 at JPMorgan
10/06/20 Raymond James
Raymond James says FDA guidance 'likely assures' no vaccine EUA before late Nov.
10/04/20 Goldman Sachs
Translate Bio initiated with a Buy at Goldman Sachs
AZN AstraZeneca
$55.29 /

+1.27 (+2.35%)

11/11/20 Oppenheimer
Amgen price target raised to $280 from $275 at Oppenheimer
11/11/20 HSBC
AstraZeneca upgraded to Hold from Reduce at HSBC
11/11/20 HSBC
AstraZeneca upgraded to Hold from Reduce at HSBC
10/23/20 Stifel
FibroGen safety data mitigates concerns of roxadustat black box, says Stifel
GSK GlaxoSmithKline
$37.03 /

-0.11 (-0.30%)

11/13/20 Morgan Stanley
GlaxoSmithKline upgraded to Equal Weight from Underweight at Morgan Stanley
11/02/20 Liberum
GlaxoSmithKline upgraded to Buy from Hold at Liberum
10/30/20 Barclays
GlaxoSmithKline price target lowered to 1,300 GBp from 1,550 GBp at Barclays
10/27/20 Truist
AnaptysBio price target raised to $27 from $20 at Truist
NVS Novartis
$87.51 /

+0.285 (+0.33%)

11/10/20 JPMorgan
Novartis price target raised to CHF 85 from CHF 82 at JPMorgan
10/26/20 JMP Securities
Kura Oncology price target raised to $33 from $22 at JMP Securities
09/29/20 Berenberg
Novartis initiated with a Buy at Berenberg
09/24/20 Barclays
Regenxbio price target lowered to $79 from $88 at Barclays
RHHBY Roche
$0.00 /

+ (+0.00%)

11/11/20 Truist
Opthea initiated with a Buy at Truist
10/16/20 UBS
Roche price target lowered to CHF 370 from CHF 390 at UBS
10/06/20 Goldman Sachs
Goldman reiterates $34 target on Kiniksa after 'impressive' data
09/29/20 Berenberg
Roche initiated with a Hold at Berenberg
BMY Bristol-Myers
$61.62 /

-0.47 (-0.76%)

11/17/20 Mizuho
Bristol-Myers Squibb CVR price target lowered to $3.34 from $6.17 at Mizuho
11/16/20 Societe Generale
Bristol-Myers upgraded to Buy from Hold at Societe Generale
11/10/20 Bernstein
Bristol-Myers initiated with a Market Perform, $72 price target at Bernstein
11/10/20 Bernstein
Bristol-Myers initiated with a Market Perform at Bernstein
SNY Sanofi
$50.47 /

-0.34 (-0.67%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PFE Pfizer
$36.70 /

+0.51 (+1.41%)

NVS Novartis
$87.51 /

+0.285 (+0.33%)

MRK Merck
$80.46 /

+0.04 (+0.05%)

LLY Eli Lilly
$145.62 /

+2.16 (+1.51%)

JNJ Johnson & Johnson
$146.33 /

-0.76 (-0.52%)

GSK GlaxoSmithKline
$37.03 /

-0.11 (-0.30%)

BMY Bristol-Myers
$61.62 /

-0.47 (-0.76%)

AZN AstraZeneca
$55.29 /

+1.27 (+2.35%)

SNY Sanofi
$50.47 /

-0.34 (-0.67%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PFE Pfizer
$36.70 /

+0.51 (+1.41%)

NVS Novartis
$87.51 /

+0.285 (+0.33%)

MRK Merck
$80.46 /

+0.04 (+0.05%)

LLY Eli Lilly
$145.62 /

+2.16 (+1.51%)

JNJ Johnson & Johnson
$146.33 /

-0.76 (-0.52%)

GSK GlaxoSmithKline
$37.03 /

-0.11 (-0.30%)

BMY Bristol-Myers
$61.62 /

-0.47 (-0.76%)

AZN AstraZeneca
$55.29 /

+1.27 (+2.35%)

SNY Sanofi
$50.47 /

-0.34 (-0.67%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PFE Pfizer
$36.70 /

+0.51 (+1.41%)

NVS Novartis
$87.51 /

+0.285 (+0.33%)

MRK Merck
$80.46 /

+0.04 (+0.05%)

LLY Eli Lilly
$145.62 /

+2.16 (+1.51%)

JNJ Johnson & Johnson
$146.33 /

-0.76 (-0.52%)

GSK GlaxoSmithKline
$37.03 /

-0.11 (-0.30%)

BMY Bristol-Myers
$61.62 /

-0.47 (-0.76%)

AZN AstraZeneca
$55.29 /

+1.27 (+2.35%)

PFE Pfizer
$36.70 /

+0.51 (+1.41%)

MRK Merck
$80.46 /

+0.04 (+0.05%)

LLY Eli Lilly
$145.62 /

+2.16 (+1.51%)

JNJ Johnson & Johnson
$146.33 /

-0.76 (-0.52%)

GSK GlaxoSmithKline
$37.03 /

-0.11 (-0.30%)

BMY Bristol-Myers
$61.62 /

-0.47 (-0.76%)

AZN AstraZeneca
$55.29 /

+1.27 (+2.35%)

On The Fly
Fly Intel: Wall Street's top stories for Friday » 16:22
11/20/20
11/20
16:22
11/20/20
16:22
PFE

Pfizer

$36.70 /

+0.51 (+1.41%)

, BNTX

BioNTech

$104.00 /

+9.17 (+9.67%)

, FL

Foot Locker

$39.30 /

-2.06 (-4.98%)

, WDAY

Workday

$209.38 /

-21.42 (-9.28%)

, FEYE

FireEye

$15.14 /

+0.91 (+6.39%)

, BA

Boeing

$199.62 /

-6.01 (-2.92%)

, MESO

Mesoblast

$13.88 /

+2.11 (+17.93%)

, NVS

Novartis

$87.51 /

+0.285 (+0.33%)

, WSM

Williams-Sonoma

$107.76 /

+6.52 (+6.44%)

, AVRO

Avrobio

$13.99 /

-2.96 (-17.46%)

, GSX

GSX Techedu

$65.66 /

-5.845 (-8.17%)

, POST

Post Holdings

$90.53 /

-6.07 (-6.28%)

The major averages slid…

ShowHide Related Items >><<
WSM Williams-Sonoma
$107.76 /

+6.52 (+6.44%)

WDAY Workday
$209.38 /

-21.42 (-9.28%)

POST Post Holdings
$90.53 /

-6.07 (-6.28%)

PFE Pfizer
$36.70 /

+0.51 (+1.41%)

NVS Novartis
$87.51 /

+0.285 (+0.33%)

MESO Mesoblast
$13.88 /

+2.11 (+17.93%)

GSX GSX Techedu
$65.66 /

-5.845 (-8.17%)

FL Foot Locker
$39.30 /

-2.06 (-4.98%)

FEYE FireEye
$15.14 /

+0.91 (+6.39%)

BNTX BioNTech
$104.00 /

+9.17 (+9.67%)

BA Boeing
$199.62 /

-6.01 (-2.92%)

AVRO Avrobio
$13.99 /

-2.96 (-17.46%)

PFE Pfizer
$36.70 /

+0.51 (+1.41%)

11/19/20
Fly Intel: Top five analyst initiations
11/19/20 Goldman Sachs
Pfizer reinstated with a Neutral at Goldman Sachs
11/17/20 Benchmark
Inovio on 'top-10 vaccine contenders list,' says Benchmark
11/17/20 Maxim
Co-Diagnostics price target lowered to $20 from $30 at Maxim
BNTX BioNTech
$104.00 /

+9.17 (+9.67%)

11/16/20 Piper Sandler
Piper boosts Moderna target to $166 after 'impressive' vaccine response
11/12/20 Canaccord
BioNTech price target raised to $115 from $112 at Canaccord
11/12/20 B. Riley Securities
Altimmune selloff on vaccine news overblown, says B. Riley Securities
FL Foot Locker
$39.30 /

-2.06 (-4.98%)

11/18/20 B. Riley Securities
Foot Locker price target raised to $36 from $30 at B. Riley Securities
11/18/20 Pivotal Research
Foot Locker price target raised to $46 from $39 at Pivotal Research
11/17/20 Wedbush
Foot Locker price target raised to $44 from $37 at Wedbush
11/16/20 Raymond James
Foot Locker price target raised to $50 from $35 at Raymond James
WDAY Workday
$209.38 /

-21.42 (-9.28%)

11/20/20 Loop Capital
Workday price target raised to $180 from $170 at Loop Capital
11/20/20 Canaccord
Workday weakness following earnings should be bought, says Canaccord
11/20/20 BMO Capital
Workday price target lowered to $260 from $265 at BMO Capital
11/20/20 Credit Suisse
Workday price target raised to $230 from $215 at Credit Suisse
FEYE FireEye
$15.14 /

+0.91 (+6.39%)

11/20/20 Barclays
FireEye downgraded to Underweight on long transformation at Barclays
11/20/20 Barclays
FireEye downgraded to Underweight from Equal Weight at Barclays
10/14/20 Baird
FireEye added as positive Fresh Pick ahead of earnings at Baird
07/29/20 JPMorgan
FireEye price target raised to $18 from $15 at JPMorgan
BA Boeing
$199.62 /

-6.01 (-2.92%)

11/19/20 Susquehanna
Boeing price target raised to $275 from $220 at Susquehanna
11/18/20 Goldman Sachs
Boeing price target raised to $245 from $231 at Goldman Sachs
11/18/20 William Blair
Boeing 737 Max approval 'a modest positive' for ViaSat, says William Blair
11/18/20
Fly Intel: Top five analyst upgrades
MESO Mesoblast
$13.88 /

+2.11 (+17.93%)

10/22/20
Fly Intel: Top five analyst initiations
10/22/20 RBC Capital
Mesoblast initiated with a Sector Perform at RBC Capital
10/05/20 Maxim
Mesoblast price target lowered to $18 from $22 at Maxim
10/02/20 H.C. Wainwright
H.C. Wainwright cuts Mesoblast target after unexpected complete response letter
NVS Novartis
$87.51 /

+0.285 (+0.33%)

11/10/20 JPMorgan
Novartis price target raised to CHF 85 from CHF 82 at JPMorgan
10/26/20 JMP Securities
Kura Oncology price target raised to $33 from $22 at JMP Securities
09/29/20 Berenberg
Novartis initiated with a Buy at Berenberg
09/24/20 Barclays
Regenxbio price target lowered to $79 from $88 at Barclays
WSM Williams-Sonoma
$107.76 /

+6.52 (+6.44%)

11/20/20 RBC Capital
Williams-Sonoma price target raised to $117 from $101 at RBC Capital
11/20/20 Loop Capital
Williams-Sonoma price target raised to $110 from $100 at Loop Capital
11/20/20 Wedbush
Williams-Sonoma price target raised to $130 from $115 at Wedbush
11/20/20 Barclays
Williams-Sonoma price target raised to $144 from $112 at Barclays
AVRO Avrobio
$13.99 /

-2.96 (-17.46%)

11/18/20 Mizuho
Avrobio price target raised to $43 from $35 at Mizuho
11/11/20 Berenberg
Biotechnology companies initiated at Berenberg
11/11/20 Berenberg
Avrobio initiated with a Buy at Berenberg
03/31/20 H.C. Wainwright
Avrobio downgraded to Neutral from Buy at H.C. Wainwright
GSX GSX Techedu
$65.66 /

-5.845 (-8.17%)

10/26/20 Barclays
GSX Techedu price target lowered to $66 from $77 at Barclays
10/22/20
Fly Intel: Top five analyst downgrades
10/22/20 Nomura
Nomura downgrades GSX Techedu to Reduce, cuts target to 'Street-low' $38
10/22/20 Nomura
GSX Techedu downgraded to Reduce from Neutral at Nomura
POST Post Holdings
$90.53 /

-6.07 (-6.28%)

06/22/20 Goldman Sachs
Post Holdings upgraded to Buy from Neutral at Goldman Sachs
05/04/20 Wells Fargo
Post Holdings price target lowered to $110 from $120 at Wells Fargo
04/09/20
Fly Intel: Top five analyst initiations
04/09/20 Citi
Post Holdings assumed with a Buy at Citi
WSM Williams-Sonoma
$107.76 /

+6.52 (+6.44%)

WDAY Workday
$209.38 /

-21.42 (-9.28%)

POST Post Holdings
$90.53 /

-6.07 (-6.28%)

PFE Pfizer
$36.70 /

+0.51 (+1.41%)

NVS Novartis
$87.51 /

+0.285 (+0.33%)

MESO Mesoblast
$13.88 /

+2.11 (+17.93%)

GSX GSX Techedu
$65.66 /

-5.845 (-8.17%)

FL Foot Locker
$39.30 /

-2.06 (-4.98%)

FEYE FireEye
$15.14 /

+0.91 (+6.39%)

BNTX BioNTech
$104.00 /

+9.17 (+9.67%)

BA Boeing
$199.62 /

-6.01 (-2.92%)

AVRO Avrobio
$13.99 /

-2.96 (-17.46%)

  • 20
    Nov
  • 23
    Jul
  • 13
    Feb
  • 06
    Feb
  • 21
    Nov
WSM Williams-Sonoma
$107.76 /

+6.52 (+6.44%)

POST Post Holdings
$90.53 /

-6.07 (-6.28%)

PFE Pfizer
$36.70 /

+0.51 (+1.41%)

NVS Novartis
$87.51 /

+0.285 (+0.33%)

GSX GSX Techedu
$65.66 /

-5.845 (-8.17%)

FEYE FireEye
$15.14 /

+0.91 (+6.39%)

BNTX BioNTech
$104.00 /

+9.17 (+9.67%)

BA Boeing
$199.62 /

-6.01 (-2.92%)

WSM Williams-Sonoma
$107.76 /

+6.52 (+6.44%)

WDAY Workday
$209.38 /

-21.42 (-9.28%)

PFE Pfizer
$36.70 /

+0.51 (+1.41%)

NVS Novartis
$87.51 /

+0.285 (+0.33%)

MESO Mesoblast
$13.88 /

+2.11 (+17.93%)

GSX GSX Techedu
$65.66 /

-5.845 (-8.17%)

FL Foot Locker
$39.30 /

-2.06 (-4.98%)

FEYE FireEye
$15.14 /

+0.91 (+6.39%)

BA Boeing
$199.62 /

-6.01 (-2.92%)

AVRO Avrobio
$13.99 /

-2.96 (-17.46%)

WSM Williams-Sonoma
$107.76 /

+6.52 (+6.44%)

WDAY Workday
$209.38 /

-21.42 (-9.28%)

PFE Pfizer
$36.70 /

+0.51 (+1.41%)

MESO Mesoblast
$13.88 /

+2.11 (+17.93%)

GSX GSX Techedu
$65.66 /

-5.845 (-8.17%)

FL Foot Locker
$39.30 /

-2.06 (-4.98%)

FEYE FireEye
$15.14 /

+0.91 (+6.39%)

BNTX BioNTech
$104.00 /

+9.17 (+9.67%)

BA Boeing
$199.62 /

-6.01 (-2.92%)

Hot Stocks
Trump announces new actions intended to limit drug prices » 14:41
11/20/20
11/20
14:41
11/20/20
14:41
JNJ

Johnson & Johnson

$146.76 /

-0.33 (-0.22%)

, LLY

Eli Lilly

$145.42 /

+1.96 (+1.37%)

, MRK

Merck

$80.68 /

+0.26 (+0.32%)

, PFE

Pfizer

$36.85 /

+0.66 (+1.82%)

, SNY

Sanofi

$50.55 /

-0.26 (-0.51%)

, AZN

AstraZeneca

$55.09 /

+1.07 (+1.98%)

, GSK

GlaxoSmithKline

$37.03 /

-0.11 (-0.30%)

, NVS

Novartis

$87.33 /

+0.11 (+0.13%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

, BMY

Bristol-Myers

$61.96 /

-0.135 (-0.22%)

President Donald Trump is…

President Donald Trump is discussing two new executive actions aimed at limiting drug prices in a press conference from the White House. Publicly traded drugmakers include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY).

ShowHide Related Items >><<
SNY Sanofi
$50.55 /

-0.26 (-0.51%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PFE Pfizer
$36.85 /

+0.66 (+1.82%)

NVS Novartis
$87.33 /

+0.11 (+0.13%)

MRK Merck
$80.68 /

+0.26 (+0.32%)

LLY Eli Lilly
$145.42 /

+1.96 (+1.37%)

JNJ Johnson & Johnson
$146.76 /

-0.33 (-0.22%)

GSK GlaxoSmithKline
$37.03 /

-0.11 (-0.30%)

BMY Bristol-Myers
$61.96 /

-0.135 (-0.22%)

AZN AstraZeneca
$55.09 /

+1.07 (+1.98%)

JNJ Johnson & Johnson
$146.76 /

-0.33 (-0.22%)

11/12/20 Chardan
Immunovant price target raised to $60 from $45 at Chardan
11/10/20 Piper Sandler
Aligos Therapeutics initiated with an Overweight at Piper Sandler
10/26/20 RBC Capital
Morphic Holding initiated with an Outperform at RBC Capital
10/14/20 Credit Suisse
Johnson & Johnson price target raised to $168 from $163 at Credit Suisse
LLY Eli Lilly
$145.42 /

+1.96 (+1.37%)

11/17/20 Mizuho
Eli Lilly price target lowered to $156 from $164 at Mizuho
11/10/20 Bernstein
Eli Lilly initiated with a Market Perform, $150 price target at Bernstein
11/10/20 Bernstein
Eli Lilly initiated with a Market Perform at Bernstein
11/10/20 SVB Leerink
Regeneron price target lowered to $643 from $653 at SVB Leerink
MRK Merck
$80.68 /

+0.26 (+0.32%)

11/10/20 Bernstein
Bernstein bullish on Merck, initiates with an Outperform
11/10/20 Bernstein
Merck initiated with an Outperform at Bernstein
11/02/20 Raymond James
Jounce Therapeutics downgraded to Market Perform at Raymond James
10/23/20
Fly Intel: Pre-market Movers
PFE Pfizer
$36.85 /

+0.66 (+1.82%)

11/19/20
Fly Intel: Top five analyst initiations
11/19/20 Goldman Sachs
Pfizer reinstated with a Neutral at Goldman Sachs
11/17/20 Benchmark
Inovio on 'top-10 vaccine contenders list,' says Benchmark
11/17/20 Maxim
Co-Diagnostics price target lowered to $20 from $30 at Maxim
SNY Sanofi
$50.55 /

-0.26 (-0.51%)

11/03/20 Morgan Stanley
Sanofi price target lowered to EUR 105 from EUR 107 at Morgan Stanley
10/30/20 JPMorgan
Sanofi price target lowered to EUR 100 from EUR 106 at JPMorgan
10/06/20 Raymond James
Raymond James says FDA guidance 'likely assures' no vaccine EUA before late Nov.
10/04/20 Goldman Sachs
Translate Bio initiated with a Buy at Goldman Sachs
AZN AstraZeneca
$55.09 /

+1.07 (+1.98%)

11/11/20 Oppenheimer
Amgen price target raised to $280 from $275 at Oppenheimer
11/11/20 HSBC
AstraZeneca upgraded to Hold from Reduce at HSBC
11/11/20 HSBC
AstraZeneca upgraded to Hold from Reduce at HSBC
10/23/20 Stifel
FibroGen safety data mitigates concerns of roxadustat black box, says Stifel
GSK GlaxoSmithKline
$37.03 /

-0.11 (-0.30%)

11/13/20 Morgan Stanley
GlaxoSmithKline upgraded to Equal Weight from Underweight at Morgan Stanley
11/02/20 Liberum
GlaxoSmithKline upgraded to Buy from Hold at Liberum
10/30/20 Barclays
GlaxoSmithKline price target lowered to 1,300 GBp from 1,550 GBp at Barclays
10/27/20 Truist
AnaptysBio price target raised to $27 from $20 at Truist
NVS Novartis
$87.33 /

+0.11 (+0.13%)

11/10/20 JPMorgan
Novartis price target raised to CHF 85 from CHF 82 at JPMorgan
10/26/20 JMP Securities
Kura Oncology price target raised to $33 from $22 at JMP Securities
09/29/20 Berenberg
Novartis initiated with a Buy at Berenberg
09/24/20 Barclays
Regenxbio price target lowered to $79 from $88 at Barclays
RHHBY Roche
$0.00 /

+ (+0.00%)

11/11/20 Truist
Opthea initiated with a Buy at Truist
10/16/20 UBS
Roche price target lowered to CHF 370 from CHF 390 at UBS
10/06/20 Goldman Sachs
Goldman reiterates $34 target on Kiniksa after 'impressive' data
09/29/20 Berenberg
Roche initiated with a Hold at Berenberg
BMY Bristol-Myers
$61.96 /

-0.135 (-0.22%)

11/17/20 Mizuho
Bristol-Myers Squibb CVR price target lowered to $3.34 from $6.17 at Mizuho
11/16/20 Societe Generale
Bristol-Myers upgraded to Buy from Hold at Societe Generale
11/10/20 Bernstein
Bristol-Myers initiated with a Market Perform, $72 price target at Bernstein
11/10/20 Bernstein
Bristol-Myers initiated with a Market Perform at Bernstein
SNY Sanofi
$50.55 /

-0.26 (-0.51%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PFE Pfizer
$36.85 /

+0.66 (+1.82%)

NVS Novartis
$87.33 /

+0.11 (+0.13%)

MRK Merck
$80.68 /

+0.26 (+0.32%)

LLY Eli Lilly
$145.42 /

+1.96 (+1.37%)

JNJ Johnson & Johnson
$146.76 /

-0.33 (-0.22%)

GSK GlaxoSmithKline
$37.03 /

-0.11 (-0.30%)

BMY Bristol-Myers
$61.96 /

-0.135 (-0.22%)

AZN AstraZeneca
$55.09 /

+1.07 (+1.98%)

SNY Sanofi
$50.55 /

-0.26 (-0.51%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PFE Pfizer
$36.85 /

+0.66 (+1.82%)

NVS Novartis
$87.33 /

+0.11 (+0.13%)

MRK Merck
$80.68 /

+0.26 (+0.32%)

LLY Eli Lilly
$145.42 /

+1.96 (+1.37%)

JNJ Johnson & Johnson
$146.76 /

-0.33 (-0.22%)

GSK GlaxoSmithKline
$37.03 /

-0.11 (-0.30%)

BMY Bristol-Myers
$61.96 /

-0.135 (-0.22%)

AZN AstraZeneca
$55.09 /

+1.07 (+1.98%)

SNY Sanofi
$50.55 /

-0.26 (-0.51%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PFE Pfizer
$36.85 /

+0.66 (+1.82%)

NVS Novartis
$87.33 /

+0.11 (+0.13%)

MRK Merck
$80.68 /

+0.26 (+0.32%)

LLY Eli Lilly
$145.42 /

+1.96 (+1.37%)

JNJ Johnson & Johnson
$146.76 /

-0.33 (-0.22%)

GSK GlaxoSmithKline
$37.03 /

-0.11 (-0.30%)

BMY Bristol-Myers
$61.96 /

-0.135 (-0.22%)

AZN AstraZeneca
$55.09 /

+1.07 (+1.98%)

PFE Pfizer
$36.85 /

+0.66 (+1.82%)

MRK Merck
$80.68 /

+0.26 (+0.32%)

LLY Eli Lilly
$145.42 /

+1.96 (+1.37%)

JNJ Johnson & Johnson
$146.76 /

-0.33 (-0.22%)

GSK GlaxoSmithKline
$37.03 /

-0.11 (-0.30%)

BMY Bristol-Myers
$61.96 /

-0.135 (-0.22%)

AZN AstraZeneca
$55.09 /

+1.07 (+1.98%)

On The Fly
Fly Intel: Wall Street's top stories at midday » 12:30
11/20/20
11/20
12:30
11/20/20
12:30
PFE

Pfizer

$36.64 /

+0.45 (+1.24%)

, BNTX

BioNTech

$101.50 /

+6.67 (+7.03%)

, FL

Foot Locker

$39.44 /

-1.915 (-4.63%)

, WDAY

Workday

$214.25 /

-16.55 (-7.17%)

, FEYE

FireEye

$15.19 /

+0.955 (+6.71%)

, BX

Blackstone

$58.77 /

+0.13 (+0.22%)

, MESO

Mesoblast

$13.93 /

+2.16 (+18.35%)

, NVS

Novartis

$87.29 /

+0.07 (+0.08%)

, WSM

Williams-Sonoma

$108.24 /

+7 (+6.91%)

, AVRO

Avrobio

$14.47 /

-2.48 (-14.63%)

, GSX

GSX Techedu

$59.25 /

-12.25 (-17.13%)

, POST

Post Holdings

$89.98 /

-6.62 (-6.85%)

The major averages are…

ShowHide Related Items >><<
WSM Williams-Sonoma
$108.24 /

+7 (+6.91%)

WDAY Workday
$214.25 /

-16.55 (-7.17%)

POST Post Holdings
$89.98 /

-6.62 (-6.85%)

PFE Pfizer
$36.64 /

+0.45 (+1.24%)

NVS Novartis
$87.29 /

+0.07 (+0.08%)

MESO Mesoblast
$13.93 /

+2.16 (+18.35%)

GSX GSX Techedu
$59.25 /

-12.25 (-17.13%)

FL Foot Locker
$39.44 /

-1.915 (-4.63%)

FEYE FireEye
$15.19 /

+0.955 (+6.71%)

BX Blackstone
$58.77 /

+0.13 (+0.22%)

BNTX BioNTech
$101.50 /

+6.67 (+7.03%)

AVRO Avrobio
$14.47 /

-2.48 (-14.63%)

PFE Pfizer
$36.64 /

+0.45 (+1.24%)

11/19/20
Fly Intel: Top five analyst initiations
11/19/20 Goldman Sachs
Pfizer reinstated with a Neutral at Goldman Sachs
11/17/20 Benchmark
Inovio on 'top-10 vaccine contenders list,' says Benchmark
11/17/20 Maxim
Co-Diagnostics price target lowered to $20 from $30 at Maxim
BNTX BioNTech
$101.50 /

+6.67 (+7.03%)

11/16/20 Piper Sandler
Piper boosts Moderna target to $166 after 'impressive' vaccine response
11/12/20 Canaccord
BioNTech price target raised to $115 from $112 at Canaccord
11/12/20 B. Riley Securities
Altimmune selloff on vaccine news overblown, says B. Riley Securities
FL Foot Locker
$39.44 /

-1.915 (-4.63%)

11/18/20 B. Riley Securities
Foot Locker price target raised to $36 from $30 at B. Riley Securities
11/18/20 Pivotal Research
Foot Locker price target raised to $46 from $39 at Pivotal Research
11/17/20 Wedbush
Foot Locker price target raised to $44 from $37 at Wedbush
11/16/20 Raymond James
Foot Locker price target raised to $50 from $35 at Raymond James
WDAY Workday
$214.25 /

-16.55 (-7.17%)

11/20/20 Loop Capital
Workday price target raised to $180 from $170 at Loop Capital
11/20/20 Canaccord
Workday weakness following earnings should be bought, says Canaccord
11/20/20 BMO Capital
Workday price target lowered to $260 from $265 at BMO Capital
11/20/20 Credit Suisse
Workday price target raised to $230 from $215 at Credit Suisse
FEYE FireEye
$15.19 /

+0.955 (+6.71%)

11/20/20 Barclays
FireEye downgraded to Underweight on long transformation at Barclays
11/20/20 Barclays
FireEye downgraded to Underweight from Equal Weight at Barclays
10/14/20 Baird
FireEye added as positive Fresh Pick ahead of earnings at Baird
07/29/20 JPMorgan
FireEye price target raised to $18 from $15 at JPMorgan
BX Blackstone
$58.77 /

+0.13 (+0.22%)

10/29/20 Oppenheimer
Blackstone upgraded to Outperform at Oppenheimer
10/29/20 Oppenheimer
Blackstone upgraded to Outperform from Perform at Oppenheimer
06/25/20
Fly Intel: Top five analyst initiations
06/25/20 UBS
Blackstone initiated with a Buy at UBS
MESO Mesoblast
$13.93 /

+2.16 (+18.35%)

10/22/20
Fly Intel: Top five analyst initiations
10/22/20 RBC Capital
Mesoblast initiated with a Sector Perform at RBC Capital
10/05/20 Maxim
Mesoblast price target lowered to $18 from $22 at Maxim
10/02/20 H.C. Wainwright
H.C. Wainwright cuts Mesoblast target after unexpected complete response letter
NVS Novartis
$87.29 /

+0.07 (+0.08%)

11/10/20 JPMorgan
Novartis price target raised to CHF 85 from CHF 82 at JPMorgan
10/26/20 JMP Securities
Kura Oncology price target raised to $33 from $22 at JMP Securities
09/29/20 Berenberg
Novartis initiated with a Buy at Berenberg
09/24/20 Barclays
Regenxbio price target lowered to $79 from $88 at Barclays
WSM Williams-Sonoma
$108.24 /

+7 (+6.91%)

11/20/20 RBC Capital
Williams-Sonoma price target raised to $117 from $101 at RBC Capital
11/20/20 Loop Capital
Williams-Sonoma price target raised to $110 from $100 at Loop Capital
11/20/20 Wedbush
Williams-Sonoma price target raised to $130 from $115 at Wedbush
11/20/20 Barclays
Williams-Sonoma price target raised to $144 from $112 at Barclays
AVRO Avrobio
$14.47 /

-2.48 (-14.63%)

11/18/20 Mizuho
Avrobio price target raised to $43 from $35 at Mizuho
11/11/20 Berenberg
Biotechnology companies initiated at Berenberg
11/11/20 Berenberg
Avrobio initiated with a Buy at Berenberg
03/31/20 H.C. Wainwright
Avrobio downgraded to Neutral from Buy at H.C. Wainwright
GSX GSX Techedu
$59.25 /

-12.25 (-17.13%)

10/26/20 Barclays
GSX Techedu price target lowered to $66 from $77 at Barclays
10/22/20
Fly Intel: Top five analyst downgrades
10/22/20 Nomura
Nomura downgrades GSX Techedu to Reduce, cuts target to 'Street-low' $38
10/22/20 Nomura
GSX Techedu downgraded to Reduce from Neutral at Nomura
POST Post Holdings
$89.98 /

-6.62 (-6.85%)

06/22/20 Goldman Sachs
Post Holdings upgraded to Buy from Neutral at Goldman Sachs
05/04/20 Wells Fargo
Post Holdings price target lowered to $110 from $120 at Wells Fargo
04/09/20
Fly Intel: Top five analyst initiations
04/09/20 Citi
Post Holdings assumed with a Buy at Citi
WSM Williams-Sonoma
$108.24 /

+7 (+6.91%)

WDAY Workday
$214.25 /

-16.55 (-7.17%)

POST Post Holdings
$89.98 /

-6.62 (-6.85%)

PFE Pfizer
$36.64 /

+0.45 (+1.24%)

NVS Novartis
$87.29 /

+0.07 (+0.08%)

MESO Mesoblast
$13.93 /

+2.16 (+18.35%)

GSX GSX Techedu
$59.25 /

-12.25 (-17.13%)

FL Foot Locker
$39.44 /

-1.915 (-4.63%)

FEYE FireEye
$15.19 /

+0.955 (+6.71%)

BX Blackstone
$58.77 /

+0.13 (+0.22%)

BNTX BioNTech
$101.50 /

+6.67 (+7.03%)

AVRO Avrobio
$14.47 /

-2.48 (-14.63%)

  • 20
    Nov
  • 23
    Jul
  • 13
    Feb
  • 06
    Feb
  • 21
    Nov
WSM Williams-Sonoma
$108.24 /

+7 (+6.91%)

POST Post Holdings
$89.98 /

-6.62 (-6.85%)

PFE Pfizer
$36.64 /

+0.45 (+1.24%)

NVS Novartis
$87.29 /

+0.07 (+0.08%)

GSX GSX Techedu
$59.25 /

-12.25 (-17.13%)

FEYE FireEye
$15.19 /

+0.955 (+6.71%)

BX Blackstone
$58.77 /

+0.13 (+0.22%)

BNTX BioNTech
$101.50 /

+6.67 (+7.03%)

WSM Williams-Sonoma
$108.24 /

+7 (+6.91%)

WDAY Workday
$214.25 /

-16.55 (-7.17%)

PFE Pfizer
$36.64 /

+0.45 (+1.24%)

NVS Novartis
$87.29 /

+0.07 (+0.08%)

MESO Mesoblast
$13.93 /

+2.16 (+18.35%)

GSX GSX Techedu
$59.25 /

-12.25 (-17.13%)

FL Foot Locker
$39.44 /

-1.915 (-4.63%)

FEYE FireEye
$15.19 /

+0.955 (+6.71%)

BX Blackstone
$58.77 /

+0.13 (+0.22%)

AVRO Avrobio
$14.47 /

-2.48 (-14.63%)

WSM Williams-Sonoma
$108.24 /

+7 (+6.91%)

WDAY Workday
$214.25 /

-16.55 (-7.17%)

PFE Pfizer
$36.64 /

+0.45 (+1.24%)

MESO Mesoblast
$13.93 /

+2.16 (+18.35%)

GSX GSX Techedu
$59.25 /

-12.25 (-17.13%)

FL Foot Locker
$39.44 /

-1.915 (-4.63%)

FEYE FireEye
$15.19 /

+0.955 (+6.71%)

BX Blackstone
$58.77 /

+0.13 (+0.22%)

BNTX BioNTech
$101.50 /

+6.67 (+7.03%)

Periodicals
Trump to release new rules aimed at lowering drug prices, WSJ reports » 06:17
11/20/20
11/20
06:17
11/20/20
06:17
JNJ

Johnson & Johnson

$147.09 /

-0.31 (-0.21%)

, LLY

Eli Lilly

$143.46 /

+3.31 (+2.36%)

, MRK

Merck

$80.42 /

+0.19 (+0.24%)

, PFE

Pfizer

$36.19 /

-0.12 (-0.33%)

, SNY

Sanofi

$50.79 /

+0.22 (+0.44%)

, AZN

AstraZeneca

$54.02 /

-0.035 (-0.06%)

, GSK

GlaxoSmithKline

$37.14 /

+0.58 (+1.59%)

, NVS

Novartis

$87.22 /

+1.37 (+1.60%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

, BMY

Bristol-Myers

$62.09 /

+0.07 (+0.11%)

, UNH

UnitedHealth

$336.98 /

-7.77 (-2.25%)

, CVS

CVS Health

$66.05 /

-0.31 (-0.47%)

, CI

Cigna

$204.78 /

-6.14 (-2.91%)

The Trump administration…

The Trump administration is planning on Friday to roll out two final rules aimed at lowering drug prices, one curbing rebates paid to middlemen in Medicare and another fixing the prices of certain prescription drugs in the U.S. to their prices in other developed countries, The Wall Street Journal's Stephanie Armour reports. Both rules are expected to take effect immediately. Drugmakers have sought to stop paying the rebates, but pharmacy-benefit managers, including Cigna's (CI) Express Scripts, CVS Health's (CVS) Caremark and UnitedHealth's (UNH) OptumRx, have opposed the rule because they retain some of the rebates. Reference Link

ShowHide Related Items >><<
UNH UnitedHealth
$336.98 /

-7.77 (-2.25%)

SNY Sanofi
$50.79 /

+0.22 (+0.44%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PFE Pfizer
$36.19 /

-0.12 (-0.33%)

NVS Novartis
$87.22 /

+1.37 (+1.60%)

MRK Merck
$80.42 /

+0.19 (+0.24%)

LLY Eli Lilly
$143.46 /

+3.31 (+2.36%)

JNJ Johnson & Johnson
$147.09 /

-0.31 (-0.21%)

GSK GlaxoSmithKline
$37.14 /

+0.58 (+1.59%)

CVS CVS Health
$66.05 /

-0.31 (-0.47%)

CI Cigna
$204.78 /

-6.14 (-2.91%)

BMY Bristol-Myers
$62.09 /

+0.07 (+0.11%)

AZN AstraZeneca
$54.02 /

-0.035 (-0.06%)

JNJ Johnson & Johnson
$147.09 /

-0.31 (-0.21%)

11/12/20 Chardan
Immunovant price target raised to $60 from $45 at Chardan
11/10/20 Piper Sandler
Aligos Therapeutics initiated with an Overweight at Piper Sandler
10/26/20 RBC Capital
Morphic Holding initiated with an Outperform at RBC Capital
10/14/20 Credit Suisse
Johnson & Johnson price target raised to $168 from $163 at Credit Suisse
LLY Eli Lilly
$143.46 /

+3.31 (+2.36%)

11/17/20 Mizuho
Eli Lilly price target lowered to $156 from $164 at Mizuho
11/10/20 Bernstein
Eli Lilly initiated with a Market Perform, $150 price target at Bernstein
11/10/20 Bernstein
Eli Lilly initiated with a Market Perform at Bernstein
11/10/20 SVB Leerink
Regeneron price target lowered to $643 from $653 at SVB Leerink
MRK Merck
$80.42 /

+0.19 (+0.24%)

11/10/20 Bernstein
Bernstein bullish on Merck, initiates with an Outperform
11/10/20 Bernstein
Merck initiated with an Outperform at Bernstein
11/02/20 Raymond James
Jounce Therapeutics downgraded to Market Perform at Raymond James
10/23/20
Fly Intel: Pre-market Movers
PFE Pfizer
$36.19 /

-0.12 (-0.33%)

11/19/20
Fly Intel: Top five analyst initiations
11/19/20 Goldman Sachs
Pfizer reinstated with a Neutral at Goldman Sachs
11/17/20 Benchmark
Inovio on 'top-10 vaccine contenders list,' says Benchmark
11/17/20 Maxim
Co-Diagnostics price target lowered to $20 from $30 at Maxim
SNY Sanofi
$50.79 /

+0.22 (+0.44%)

11/03/20 Morgan Stanley
Sanofi price target lowered to EUR 105 from EUR 107 at Morgan Stanley
10/30/20 JPMorgan
Sanofi price target lowered to EUR 100 from EUR 106 at JPMorgan
10/06/20 Raymond James
Raymond James says FDA guidance 'likely assures' no vaccine EUA before late Nov.
10/04/20 Goldman Sachs
Translate Bio initiated with a Buy at Goldman Sachs
AZN AstraZeneca
$54.02 /

-0.035 (-0.06%)

11/11/20 Oppenheimer
Amgen price target raised to $280 from $275 at Oppenheimer
11/11/20 HSBC
AstraZeneca upgraded to Hold from Reduce at HSBC
11/11/20 HSBC
AstraZeneca upgraded to Hold from Reduce at HSBC
10/23/20 Stifel
FibroGen safety data mitigates concerns of roxadustat black box, says Stifel
GSK GlaxoSmithKline
$37.14 /

+0.58 (+1.59%)

11/13/20 Morgan Stanley
GlaxoSmithKline upgraded to Equal Weight from Underweight at Morgan Stanley
11/02/20 Liberum
GlaxoSmithKline upgraded to Buy from Hold at Liberum
10/30/20 Barclays
GlaxoSmithKline price target lowered to 1,300 GBp from 1,550 GBp at Barclays
10/27/20 Truist
AnaptysBio price target raised to $27 from $20 at Truist
NVS Novartis
$87.22 /

+1.37 (+1.60%)

11/10/20 JPMorgan
Novartis price target raised to CHF 85 from CHF 82 at JPMorgan
10/26/20 JMP Securities
Kura Oncology price target raised to $33 from $22 at JMP Securities
09/29/20 Berenberg
Novartis initiated with a Buy at Berenberg
09/24/20 Barclays
Regenxbio price target lowered to $79 from $88 at Barclays
RHHBY Roche
$0.00 /

+ (+0.00%)

11/11/20 Truist
Opthea initiated with a Buy at Truist
10/16/20 UBS
Roche price target lowered to CHF 370 from CHF 390 at UBS
10/06/20 Goldman Sachs
Goldman reiterates $34 target on Kiniksa after 'impressive' data
09/29/20 Berenberg
Roche initiated with a Hold at Berenberg
BMY Bristol-Myers
$62.09 /

+0.07 (+0.11%)

11/17/20 Mizuho
Bristol-Myers Squibb CVR price target lowered to $3.34 from $6.17 at Mizuho
11/16/20 Societe Generale
Bristol-Myers upgraded to Buy from Hold at Societe Generale
11/10/20 Bernstein
Bristol-Myers initiated with a Market Perform, $72 price target at Bernstein
11/10/20 Bernstein
Bristol-Myers initiated with a Market Perform at Bernstein
UNH UnitedHealth
$336.98 /

-7.77 (-2.25%)

11/17/20 Piper Sandler
Amazon entry into Pharmacy makes 'great deal of sense,' says Piper Sandler
11/11/20 Piper Sandler
UnitedHealth price target raised to $409 from $385 at Piper Sandler
11/09/20 Mizuho
UnitedHealth price target raised to $380 from $361 at Mizuho
11/05/20 Credit Suisse
UnitedHealth price target raised to $395 from $355 at Credit Suisse
CVS CVS Health
$66.05 /

-0.31 (-0.47%)

11/17/20 Oppenheimer
Amazon's Pharmacy push should continue to disrupt supply chain, says Oppenheimer
11/17/20 Goldman Sachs
Goldman says Amazon news likely to pressure entire pharmacy supply chain
11/11/20 Piper Sandler
CVS Health price target raised to $76 from $72 at Piper Sandler
CI Cigna
$204.78 /

-6.14 (-2.91%)

11/11/20 Deutsche Bank
Cigna price target raised to $280 from $253 at Deutsche Bank
UNH UnitedHealth
$336.98 /

-7.77 (-2.25%)

SNY Sanofi
$50.79 /

+0.22 (+0.44%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PFE Pfizer
$36.19 /

-0.12 (-0.33%)

NVS Novartis
$87.22 /

+1.37 (+1.60%)

MRK Merck
$80.42 /

+0.19 (+0.24%)

LLY Eli Lilly
$143.46 /

+3.31 (+2.36%)

JNJ Johnson & Johnson
$147.09 /

-0.31 (-0.21%)

GSK GlaxoSmithKline
$37.14 /

+0.58 (+1.59%)

CVS CVS Health
$66.05 /

-0.31 (-0.47%)

CI Cigna
$204.78 /

-6.14 (-2.91%)

BMY Bristol-Myers
$62.09 /

+0.07 (+0.11%)

AZN AstraZeneca
$54.02 /

-0.035 (-0.06%)

UNH UnitedHealth
$336.98 /

-7.77 (-2.25%)

SNY Sanofi
$50.79 /

+0.22 (+0.44%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PFE Pfizer
$36.19 /

-0.12 (-0.33%)

NVS Novartis
$87.22 /

+1.37 (+1.60%)

MRK Merck
$80.42 /

+0.19 (+0.24%)

LLY Eli Lilly
$143.46 /

+3.31 (+2.36%)

JNJ Johnson & Johnson
$147.09 /

-0.31 (-0.21%)

GSK GlaxoSmithKline
$37.14 /

+0.58 (+1.59%)

CVS CVS Health
$66.05 /

-0.31 (-0.47%)

CI Cigna
$204.78 /

-6.14 (-2.91%)

BMY Bristol-Myers
$62.09 /

+0.07 (+0.11%)

AZN AstraZeneca
$54.02 /

-0.035 (-0.06%)

UNH UnitedHealth
$336.98 /

-7.77 (-2.25%)

SNY Sanofi
$50.79 /

+0.22 (+0.44%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PFE Pfizer
$36.19 /

-0.12 (-0.33%)

NVS Novartis
$87.22 /

+1.37 (+1.60%)

MRK Merck
$80.42 /

+0.19 (+0.24%)

LLY Eli Lilly
$143.46 /

+3.31 (+2.36%)

JNJ Johnson & Johnson
$147.09 /

-0.31 (-0.21%)

GSK GlaxoSmithKline
$37.14 /

+0.58 (+1.59%)

CVS CVS Health
$66.05 /

-0.31 (-0.47%)

BMY Bristol-Myers
$62.09 /

+0.07 (+0.11%)

AZN AstraZeneca
$54.02 /

-0.035 (-0.06%)

UNH UnitedHealth
$336.98 /

-7.77 (-2.25%)

PFE Pfizer
$36.19 /

-0.12 (-0.33%)

MRK Merck
$80.42 /

+0.19 (+0.24%)

LLY Eli Lilly
$143.46 /

+3.31 (+2.36%)

JNJ Johnson & Johnson
$147.09 /

-0.31 (-0.21%)

GSK GlaxoSmithKline
$37.14 /

+0.58 (+1.59%)

CVS CVS Health
$66.05 /

-0.31 (-0.47%)

CI Cigna
$204.78 /

-6.14 (-2.91%)

BMY Bristol-Myers
$62.09 /

+0.07 (+0.11%)

AZN AstraZeneca
$54.02 /

-0.035 (-0.06%)

Thursday
Hot Stocks
Mesoblast enters into global collaboration on Remestemcel-L with Novartis » 18:59
11/19/20
11/19
18:59
11/19/20
18:59
MESO

Mesoblast

$11.77 /

-0.01 (-0.08%)

, NVS

Novartis

$87.22 /

+1.37 (+1.60%)

Mesoblast (MESO)…

Mesoblast (MESO) announced that it has entered into an exclusive worldwide license and collaboration agreement with Novartis (NVS) for the development, manufacture and commercialization of Mesoblast's mesenchymal stromal cell product remestemcel-L, with an initial focus on the development of the treatment of acute respiratory distress syndrome, including that associated with COVID-19. As per Key Transaction Terms, Novartis will make a $50M upfront payment including $25M in equity; From the initiation of a Phase 3 trial in all-cause ARDS, Novartis will fully fund global clinical development for all-cause ARDS and potentially other respiratory indications; Mesoblast may receive a total of US$505 million pending achievement of pre-commercialization milestones for ARDS indications. Mesoblast Chief Executive Dr Silviu Itescu stated: "Our collaboration with Novartis will help ensure that remestemcel-L could become available to the many patients suffering from ARDS, the principal cause of mortality in COVID-19 infection. This agreement is in line with our corporate strategy to collaborate and partner with world-leading major pharma companies in order to maximize market access for our innovative cellular medicines."

ShowHide Related Items >><<
NVS Novartis
$87.22 /

+1.37 (+1.60%)

MESO Mesoblast
$11.77 /

-0.01 (-0.08%)

MESO Mesoblast
$11.77 /

-0.01 (-0.08%)

10/22/20
Fly Intel: Top five analyst initiations
10/22/20 RBC Capital
Mesoblast initiated with a Sector Perform at RBC Capital
10/05/20 Maxim
Mesoblast price target lowered to $18 from $22 at Maxim
10/02/20 H.C. Wainwright
H.C. Wainwright cuts Mesoblast target after unexpected complete response letter
NVS Novartis
$87.22 /

+1.37 (+1.60%)

11/10/20 JPMorgan
Novartis price target raised to CHF 85 from CHF 82 at JPMorgan
10/26/20 JMP Securities
Kura Oncology price target raised to $33 from $22 at JMP Securities
09/29/20 Berenberg
Novartis initiated with a Buy at Berenberg
09/24/20 Barclays
Regenxbio price target lowered to $79 from $88 at Barclays
NVS Novartis
$87.22 /

+1.37 (+1.60%)

MESO Mesoblast
$11.77 /

-0.01 (-0.08%)

NVS Novartis
$87.22 /

+1.37 (+1.60%)

NVS Novartis
$87.22 /

+1.37 (+1.60%)

MESO Mesoblast
$11.77 /

-0.01 (-0.08%)

MESO Mesoblast
$11.77 /

-0.01 (-0.08%)

Hot Stocks
Novartis says new data at ASH to reinforce breadth of hematology portfolio » 09:55
11/19/20
11/19
09:55
11/19/20
09:55
NVS

Novartis

$86.32 /

+0.47 (+0.55%)

Novartis announced that…

Novartis announced that new research data from a broad range of hematology medicines and investigational therapies will be presented at the 62nd American Society of Hematology, or ASH, Annual Meeting & Exposition, taking place virtually December 5-8. "More than 65 abstracts from Novartis-sponsored and investigator-initiated trials that include results for asciminib, Kymriah, Jakavi, sabatolimab and Adakveo underscore the Novartis vision to deliver transformative innovation to address unmet medical needs," the company said. "Our research and development strategy focuses on developing transformative treatments with the aspiration of dramatically improving quality of life and addressing the underlying disease process. The ASH presentations demonstrate how we are pursuing these goals in hematology with research that focuses on developing advanced therapeutic approaches across an array of blood cancers and difficult-to-treat hematologic diseases," added Susanne Schaffert, PhD, President, Novartis Oncology.

ShowHide Related Items >><<
NVS Novartis
$86.32 /

+0.47 (+0.55%)

NVS Novartis
$86.32 /

+0.47 (+0.55%)

11/10/20 JPMorgan
Novartis price target raised to CHF 85 from CHF 82 at JPMorgan
10/26/20 JMP Securities
Kura Oncology price target raised to $33 from $22 at JMP Securities
09/29/20 Berenberg
Novartis initiated with a Buy at Berenberg
09/24/20 Barclays
Regenxbio price target lowered to $79 from $88 at Barclays
NVS Novartis
$86.32 /

+0.47 (+0.55%)

NVS Novartis
$86.32 /

+0.47 (+0.55%)

NVS Novartis
$86.32 /

+0.47 (+0.55%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.